spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  mesenchymal stem cell 

 HSMN NewsFeed - 27 May 2025
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn(R) Phase 3b ALS Clinical Trials
Regenerative Medicine Neurology
 HSMN NewsFeed - 19 May 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 10 Apr 2025
BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 27 Mar 2023
BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review Biologics License Application for NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 27 Dec 2022
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 10 Nov 2022
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 15 Sep 2022
BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of Results from the NurOwn(R) Phase 2 Progressive MS Trial in Multiple Sclerosis Journal
Regenerative Medicine Neurology
 HSMN NewsFeed - 29 Mar 2022
Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells(R) treatment for Traumatic Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 27 Dec 2021
FDA Authorizes Further NurOwn(R) Dosing Under Expanded Access Program
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing
 HSMN NewsFeed - 19 May 2021
SoftWave Tissue Regeneration Technologies Receives FDA Clearance for Blood Circulation Increase, Minor Aches and Pains Relief and Connective Tissue Activation
Devices FDA
 HSMN NewsFeed - 14 Dec 2020
BrainStorm Announces NurOwn(R) Expanded Access Program
Regenerative Medicine Neurology Product Launch
 HSMN NewsFeed - 23 Nov 2020
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
Regenerative Medicine Neurology
 HSMN NewsFeed - 17 Nov 2020
BrainStorm Announces Topline Results from NurOwn(R) Phase 3 ALS Study
Regenerative Medicine Neurology
 HSMN NewsFeed - 21 Oct 2020
FDA Grants Fast Track Status to Aegle Therapeutics' AGLE-102 for the Treatment of Dystrophic Epidermolysis Bullosa
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 7 Oct 2020
Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory Respiratory Conditions including COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 29 Sep 2020
Aegle Therapeutics Completes $6.5M Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 26 Jun 2020
Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jun 2020
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 27 May 2020
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 7 May 2020
Camber Spine Technologies Announces Nationwide Launch Of SPIRA(R)-C Integrated And FORTICO Anterior Cervical Plate
Devices Orthopaedic Neurosurgery FDA Product Launch
 HSMN NewsFeed - 18 Oct 2018
Positive Results of Orthopedic Treatment With the Use of ApoGraft(TM) Enriched Stem Cells Derived From Fat Tissues
Regenerative Medicine Orthopaedic
 HSMN NewsFeed - 28 Sep 2018
LYNCH Biologics Closes on Transaction to Purchase GEM 21S(R) Growth Factor Enhanced Matrix for Dental Bone Regeneration
Devices Biopharmaceuticals Dental Acquisitions
 HSMN NewsFeed - 29 Aug 2018
Longeveron Appoints Arin Maercks Chief Commercial Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 16 Jul 2018
NeuroTrauma Sciences and Henry Ford Health System Announce Research and License Agreements to Develop Exosome Technology for Neurological Injury
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 12 Jun 2018
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 23 May 2016
NuVasive Launches Next Generation Biologics Technology
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 28 Jan 2016
Cynata Receives Favourable Advice from UK Regulatory Authority
Regenerative Medicine Regulatory
 HSMN NewsFeed - 17 Feb 2015
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 14 Jan 2015
Amniox Medical Appoints Thomas J. Dugan as Chief Executive Officer
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 26 Sep 2014
Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America over SB623, Therapy for Stroke
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 29 Jan 2014
Bioheart Announces First Adipose Derived Stem Cell Implantation in Azerbaijan
Regnerative Medicine
 HSMN NewsFeed - 1 Mar 2013
Osiris Therapeutics Establishes Direct Sales Force for Grafix(R)
Devices Regenerative Medicine Wound Care Distribution
 HSMN NewsFeed - 22 Oct 2012
Osiris Therapeutics Names Lode Debrabandere Chief Operating Officer
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 28 Sep 2012
Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen
Regenerative Medicine
 HSMN NewsFeed - 6 Apr 2012
Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
Devices Orthopaedic FDA
 HSMN NewsFeed - 2 Apr 2012
AlloCure Raises $25 Million Series B Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Aug 2011
Medistem Submits Response to FDA Clinical Hold
Regenerative Medicine FDA
 HSMN NewsFeed - 24 Jan 2011
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 5 Oct 2010
Alphatec Spine, Inc. Releases PureGen(TM) Osteoprogenitor Cell Allograft to Facilitate Bone Regeneration and Announces First Patient Procedure Performed in the World
Devices Regenerative Medicine Orthopaedic Neurosurgery
 HSMN NewsFeed - 6 Jul 2010
AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Jun 2010
Derma Sciences Receives CE Mark for ALGICELL(R) Ag
Devices Wound Care Regulatory
 HSMN NewsFeed - 11 May 2010
BrainStorm Announces Significant Milestones Achieved and 2009 Review
Regenerative Medicine Neurology
 HSMN NewsFeed - 4 May 2010
Derma Sciences Launches XTRASORB(TM) Foam Wound Dressing
Devices Wound Care
 HSMN NewsFeed - 19 Mar 2010
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
Regenerative Medicine Neurology
 HSMN NewsFeed - 10 Mar 2010
SANUWAVE Health's Technology Shown to Successfully Treat Nonunion Fractures of the Tibia
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 25 Feb 2010
Derma Sciences Finalizes Licensing Agreement for Worldwide Rights to MEDIHONEY(R)
Devices Wound Care Licensing
 HSMN NewsFeed - 24 Feb 2010
New Study Demonstrates Effectiveness of Prochymal as a Rescue Therapy for Pediatric Patients with Severe Graft vs. Host Disease
Biopharmaceuticals
 HSMN NewsFeed - 18 Feb 2010
Derma Sciences Signs Contract With Leading Wound Care Company for Exclusive Distribution of BIOGUARD(TM) Barrier Dressings
Devices Wound Care Distribution
 HSMN NewsFeed - 13 Jan 2010
Alphatec Spine, Inc. Enters Into Exclusive Distribution Agreement With Parcell Spine, LLC
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 8 Sep 2009
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2009
NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
Regenerative Medicine Licensing Wound Care
 HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Regenerative Medicine Cardiology
 HSMN NewsFeed - 15 Jan 2009
Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program
Regenerative Medicine FDA
 HSMN NewsFeed - 15 Jan 2009
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
Regenerative Medicine FDA
 HSMN NewsFeed - 5 Dec 2008
Osiris Receives Approval for Prochymal Expanded Access Program in Canada
Biopharmaceuticals Regenerative Medicine Regulatory
 HSMN NewsFeed - 8 May 2008
Osiris and NuVasive Enter into Definitive Agreement for Osteocel(R)
Regenerative Medicine
 HSMN NewsFeed - 8 May 2008
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Regenerative Medicine FDA
 HSMN NewsFeed - 24 Apr 2008
AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship
Neurosurgery
 HSMN NewsFeed - 7 Jan 2008
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
Regenerative Medicine Cardiology
 HSMN NewsFeed - 10 Dec 2007
Osiris Therapeutics Reports Positive Results for Prochymal(TM) as a Rescue Agent in Pediatric Patients with End-Stage Graft vs. Host Disease
Regenerative Medicine
 HSMN NewsFeed - 27 Nov 2007
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
Regenerative Medicine Orthopaedic
 HSMN NewsFeed - 8 Nov 2007
New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
Regenerative Medicine
 HSMN NewsFeed - 8 Oct 2007
BrainStorm on the Verge of a Breakthrough Towards Developing a Cure for Lou Gehrig's Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 1 Oct 2007
Axcan Licenses Rights to Cx401, an Innovative Biological Product in Development for the Treatment of Perianal Fistulas, a Significant Unmet Medical Need
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 17 Sep 2007
BioLife Solutions' CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
Regenerative Medicine
 HSMN NewsFeed - 21 Jun 2007
Tissue Regeneration Therapeutics Inc. Announces $20 M Stem Cell License to Stem Cell Authority Ltd. for US Market
Regenerative Medicine Licensing
 HSMN NewsFeed - 14 Feb 2007
Pluristem Announces Private Equity Investment of $8M
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 8 Jan 2007
Osiris Therapeutics Receives FDA Fast Track Status for Its Crohn's Disease Stem Cell Therapy and Clearance to Start Phase III Clinical Trial
Regenerative Medicine Gastroenterology
 HSMN NewsFeed - 9 Dec 2006
Osiris Therapeutics Provides Update on Phase II Trial Evaluating PROCHYMAL(TM) for the Treatment of Acute Graft vs. Host Disease
Biopharmaceuticals
 HSMN NewsFeed - 9 Nov 2006
Osiris Therapeutics Reports Positive Phase II Results Using PROCHYMAL(TM) for the Treatment of Acute Graft vs. Host Disease
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 19 Oct 2006
Osiris Therapeutics Reports Positive Phase II Results Using PROCHYMAL(TM) in Treatment-Resistant Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 17 Oct 2006
Osiris is Granted European Manufacturing Certification for PROCHYMAL(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Oct 2006
Osiris Therapeutics Receives Approval from Health Canada to Conduct Phase III Clinical Trial for Lead Stem Cell Drug
Biopharmaceuticals Regenerative Medicine Regulatory
 HSMN NewsFeed - 22 Sep 2006
Blackstone Medical, Inc. Advances Spine Treatment with New Product Launches at NASS '06
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 5 Jul 2006
Geron Presents New Data That Document Progress in Development of Therapeutic Products from Human Embryonic Stem Cells
Biopharmaceuticals Regenerative Medicine
Return to NewsFeed  

 Additional items found! 14

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 14 additional stories matching:
mesenchymal stem cell
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.